SWANBIO THERAPEUTICS
SwanBio Therapeutics is a developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological diseases. The company's technology focuses on the development and commercialisation of genetically defined therapies for the treatment of neurological disorders.
SWANBIO THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Bala Cynwyd, Pennsylvania, United States
Country:
United States
Website Url:
http://www.swanbiotx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
118 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Apple Mobile Web Clips Icon Google Font API Google Analytics Google Maps Content Delivery Network Global Site Tag Nginx
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Syncona Partners LLP
Syncona Partners LLP investment in Venture Round - SwanBio Therapeutics
Mass General Brigham Ventures
Mass General Brigham Ventures investment in Series B - SwanBio Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series B - SwanBio Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series A - SwanBio Therapeutics
Partners Innovation Fund
Partners Innovation Fund investment in Series A - SwanBio Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Seed Round - SwanBio Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-01 | SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer |
Official Site Inspections
http://www.swanbiotx.com
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SwanBio Therapeutics"
SwanBio Therapeutics
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, genetically defined neurological conditions.See details»
SwanBio Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] SwanBio Therapeutics is a developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological …See details»
SwanBio Evolves Leadership Team with Appointment of Executive …
Oct 16, 2023 SwanBio is supported by long-term, committed investment partners, including its primary investors Syncona, Ltd. and Mass General Brigham Ventures. For more information, …See details»
SwanBio Therapeutics Named 2021 Emerging Company of the …
The annual award recognizes a Pennsylvania-based company or organization of 100 employees or fewer that has experienced significant growth and/or achievement, while contributing …See details»
SwanBio Therapeutics: Contact Details and Business Profile
Swanbiotx.com; 2 215990XXXX; 610801XXXX; Carolyn Carroll Chief People Officer at SwanBio Therapeutics United States View. 2 comcast.net; swanbiotx.com; 4 423324XXXX; …See details»
SwanBio Therapeutics - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SwanBio Therapeutics of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
SwanBio Therapeutics - VentureRadar
Similar Companies: ReGenX Biosciences USA Publicly Traded REGENXBIO Inc. is the leading next-generation AAV gene therapy company, developing a new class of personalized …See details»
SwanBio Therapeutics - Craft
SwanBio Therapeutics is a gene therapy company developing medicines for the treatment of neurological diseases. It uses adeno-associated virus (AAV) to deliver therapeutic genes to …See details»
SwanBio Therapeutics Appoints Marita James, CPA, as Chief …
PHILADELPHIA, March 23, 2021. SwanBio Therapeutics, a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological …See details»
SwanBio Evolves Leadership Team with Appointment of Executive …
Oct 16, 2023 “On behalf of both SwanBio and Syncona, I want to express our sincere gratitude to Tom for his steadfast leadership and vital contributions to the organization during his four …See details»
SwanBio Therapeutics - Overview, News & Similar companies
SwanBio Therapeutics Confirms Substantial Burden of Disease of Adrenomyeloneuropathy (AMN) in Both Men and Women PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics, …See details»
SwanBio Therapeutics
SwanBio Therapeutics is researching and developing novel gene therapies for people living with neurological disorders. Historically, neurological disorders have been challenging targets for …See details»
SwanBio Therapeutics Announces FDA Investigational New Drug …
Company to a truly integrated research and development organization, underscoring the expertise of our team and potential of our technology platform,” said Tom Anderson, chief executive …See details»
SwanBio Therapeutics Announces FDA Investigational New Drug
Jan 25, 2022 SwanBio’s lead program is being advanced toward clinical development for the treatment of adrenomyeloneuropathy (AMN). SwanBio is supported by long-term, committed …See details»
SwanBio Therapeutics Announces $56 Million Series B Financing to ...
May 18, 2022 For more information, visit SwanBioTx.com. Media Contact: Lara Furst +1-703-946-0183. [email protected] Investor Contact: Chelcie Lister +1-910-777-3049. …See details»
SwanBio Evolves Leadership Team with Appointment of Executive …
Oct 16, 2023 PHILADELPHIA--(BUSINESS WIRE)-- SwanBio Therapeutics, a gene therapy company developing AAV-based therapies for the treatment of devastating, inherited …See details»
SwanBio Therapeutics Company Overview, Contact Details
Oct 4, 2023 [email protected]: [email protected]: 98%. [email protected]: [email protected]: 1%. [email protected]: [email protected]: 1%. See more …See details»
SwanBio Therapeutics
Before consulting, she served as CFO of two global clinical research organizations, QPS Group Holdings, LLC and Frontage Laboratories, Inc., where she helped guide each organization …See details»
Swanbio Company Information - Funding, Investors, and More
Https://www.swanbiotx.com; Funding series. Funding Series Analysis. The company Swanbio has raised a total of $52m in funding over 1 rounds. Key Insights: Swanbio Series A round, April …See details»
Patients and Families Resources | SwanBio Therapeutics
For any inquiries related to SwanBio’s clinical trials or studies, please email us at [email protected] or call us at +1 (267) 417-6356. ... National Organization for Rare …See details»